- Home
- APCX vs EDSA Comparison
APCX vs EDSA Comparison
Compare APCX & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APCX
- EDSA
- Stock Information
- Founded
- APCX 2006
- EDSA 2015
- Country
- APCX United States
- EDSA Canada
- Employees
- APCX N/A
- EDSA N/A
- Industry
- APCX Finance: Consumer Services
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- APCX Finance
- EDSA Health Care
- Exchange
- APCX Nasdaq
- EDSA Nasdaq
- Market Cap
- APCX 15.2M
- EDSA 13.8M
- IPO Year
- APCX N/A
- EDSA N/A
- Fundamental
- Price
- APCX $0.70
- EDSA $4.30
- Analyst Decision
- APCX
- EDSA Strong Buy
- Analyst Count
- APCX 0
- EDSA 2
- Target Price
- APCX N/A
- EDSA $39.00
- AVG Volume (30 Days)
- APCX 273.2K
- EDSA 13.5K
- Earning Date
- APCX 11-12-2024
- EDSA 08-09-2024
- Dividend Yield
- APCX N/A
- EDSA N/A
- EPS Growth
- APCX N/A
- EDSA N/A
- EPS
- APCX N/A
- EDSA N/A
- Revenue
- APCX $462,000.00
- EDSA N/A
- Revenue This Year
- APCX $1,315.48
- EDSA N/A
- Revenue Next Year
- APCX N/A
- EDSA N/A
- P/E Ratio
- APCX N/A
- EDSA N/A
- Revenue Growth
- APCX 3.59
- EDSA N/A
- 52 Week Low
- APCX $0.44
- EDSA $2.50
- 52 Week High
- APCX $3.23
- EDSA $6.46
- Technical
- Relative Strength Index (RSI)
- APCX 53.11
- EDSA 48.64
- Support Level
- APCX $0.55
- EDSA $4.20
- Resistance Level
- APCX $0.62
- EDSA $4.44
- Average True Range (ATR)
- APCX 0.06
- EDSA 0.26
- MACD
- APCX 0.02
- EDSA -0.02
- Stochastic Oscillator
- APCX 85.29
- EDSA 30.00
About APCX AppTech Payments Corp.
AppTech Payments Corp is a FinTech company utilizing various payment processing and digital banking technologies to complement core merchant services capabilities. The company's patented and proprietary software will provide progressive and adaptable products that are available through a suite of synergistic offerings directly to merchants, banking institutions, and business enterprises. It is developing a secure digital payments and banking platform that powers commerce experiences for clients and customers. Based upon industry standards for payment and banking protocols, the company will offer standalone products and fully integrated solutions that deliver unparalleled payments, banking, and financial services experiences.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.